Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

The Increase in CD14+CD16+ Monocytes is Correlated with Cardiovascular Disease Risk Marker in Type 2 Diabetes

The Indonesian Biomedical Journal · Vol. 16 No. 1 (2024) · hlm. 79–87

DOI
10.18585/inabj.v16i1.2798
ISSN
2085-3297, 2355-9179
Terbit
2024-02-23
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Type 2 Diabetes (T2D) impairs the innate immune system including monocytes. Monocytes are divided into two subgroups depending on the expression of cluster of differentiation (CD)14 and CD16 receptors, namely CD14+CD16- and CD14+CD16+. CD14+CD16+ are proinflammatory monocytes and develop into M1 type macrophages, which contribute to foam cell production, a risk factor for cardiovascular disease (CVD). Therefore, it is important to determine the influence of T2D conditions on changes in monocyte subsets and whether these changes correlate with CVD risk markers.METHODS: Peripheral blood mononuclear cell (PBMC) was obtained from 10 T2D subjects and 10 healthy donors. Subsequently, PBMC was incubated for 24 hours with and without 10 mL lipopolysaccharide. Flow cytometry was used to evaluate CD14 and CD16 expression, while multiplex immunoassays were applied to measure interleukin (IL)-1b and IL-10 concentrations in supernatants.RESULTS: In T2D, the percentage of CD14+CD16+ monocytes increased (p=0.07), and an increase in CD14+CD16+ monocytes more than 6.8% was linked with CVD risk markers (r=10.146, p=0.002). Meanwhile, inflammatory mediators released by monocytes shown an increase in IL-1b (p=0.041) but not in IL-10 (p=0.082) in T2D subjects. Fasting blood glucose levels were also found to be substantially linked with an increase in CD14+CD16+ monocytes (r=0.530, p=0.016).CONCLUSION: T2D patients had a higher percentage of CD14+CD16+ monocytes and IL-1b levels than healthy donors. An increase in CD14+CD16+ monocytes above 6.8% associated with CVD risk markers in T2D patients.KEYWORDS: type 2 diabetes, monocytes, CD14, CD16, cardiovaskular disease risk marker

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 108 tautan kepenulisan bersama · 41 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • Hasanuddin University
  • Universitas Trisakti
  • National Research and Innovation Agency
  • Padjadjaran University
  • Universitas Airlangga
  • SEAMEO Regional Center for Food and Nutrition
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Andrijono AndrijonoUniversity of Indonesia4
Tjam Diana SamaraUniversitas Trisakti3
Isabella Kurnia LiemUniversity of Indonesia3
Ferry SandraUniversitas Trisakti3
April Hari WardhanaNational Research and Innovation Agency2
Dyah Haryuningtyas SawitriAfiliasi tidak diketahui2
Mohamad SadikinUniversity of Indonesia2
Ninik MudjihartiniUniversity of Indonesia2
Andi WijayaHasanuddin University2
Sri Widia A. JusmanUniversity of Indonesia2
Miswar FattahAfiliasi tidak diketahui2
Reni ParamitaUniversity of Indonesia1
Hastuti Handayani S PurbaNational Research and Innovation Agency1
Febriana Catur IswantiUniversity of Indonesia1
Wawan MulyawanUniversity of Indonesia1
Abdul Halim SadikinUniversity of Indonesia1
Fitrine EkawastiNational Research and Innovation Agency1
Sri Widia A. JusmanUniversity of Indonesia1
Ahmad Aulia JusufUniversity of Indonesia1
K KartiniUniversitas Trisakti1
Maria EkawatiUniversity of Indonesia1
Taniawati SupaliUniversity of Indonesia1
Suriyani TanUniversitas Trisakti1
Jeffry Adijaya SusatyoUniversity of Indonesia1
Mas Rizky A. A. SyamsunarnoPadjadjaran University1
Keri LestariPadjadjaran University1
Rina TrianaPadjadjaran University1
Widjaja LukitoSEAMEO Regional Center for Food and Nutrition1
Marsetio DonoseputroUniversitas Airlangga1
Bambang SutrisnaUniversity of Indonesia1
Fitriyadi KusumaUniversity of Indonesia1
Laila NurannaUniversity of Indonesia1
Sri Mutya SekarutamiUniversity of Indonesia1
Ilhamjaya PatellongiHasanuddin University1
Ritawaty RitawatyHasanuddin University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">The Increase in CD14+CD16+ Monocytes is Correlated with Cardiovascular Disease Risk Marker in Type 2 Diabetes</dc:title><dc:creator>Ujang Saeful Hikmat</dc:creator><dc:creator>Ani Retno Prijanti</dc:creator><dc:creator>Heri Wibowo</dc:creator><dc:creator>Indriyanti Rafi Sukmawati</dc:creator><dc:creator>Dicky L. Tahapary</dc:creator><dc:subject>type 2 diabetes</dc:subject><dc:subject>CD14+CD16+ monocytes</dc:subject><dc:subject>monocyte subsets</dc:subject><dc:subject>cardiovascular risk</dc:subject><dc:subject>IL-1β</dc:subject><dc:subject>IL-10</dc:subject><dc:subject>lipopolysaccharide</dc:subject><dc:subject>fasting blood glucose</dc:subject><dc:subject>M1 macrophages</dc:subject><dc:subject>innate immunity</dc:subject><dc:subject>inflammation</dc:subject><dc:description xml:lang="en">BACKGROUND: Type 2 Diabetes (T2D) impairs the innate immune system including monocytes. Monocytes are divided into two subgroups depending on the expression of cluster of differentiation (CD)14 and CD16 receptors, namely CD14+CD16- and CD14+CD16+. CD14+CD16+ are proinflammatory monocytes and develop into M1 type macrophages, which contribute to foam cell production, a risk factor for cardiovascular disease (CVD). Therefore, it is important to determine the influence of T2D conditions on changes in monocyte subsets and whether these changes correlate with CVD risk markers.METHODS: Peripheral blood mononuclear cell (PBMC) was obtained from 10 T2D subjects and 10 healthy donors. Subsequently, PBMC was incubated for 24 hours with and without 10 mL lipopolysaccharide. Flow cytometry was used to evaluate CD14 and CD16 expression, while multiplex immunoassays were applied to measure interleukin (IL)-1b and IL-10 concentrations in supernatants.RESULTS: In T2D, the percentage of CD14+CD16+ monocytes increased (p=0.07), and an increase in CD14+CD16+ monocytes more than 6.8% was linked with CVD risk markers (r=10.146, p=0.002). Meanwhile, inflammatory mediators released by monocytes shown an increase in IL-1b (p=0.041) but not in IL-10 (p=0.082) in T2D subjects. Fasting blood glucose levels were also found to be substantially linked with an increase in CD14+CD16+ monocytes (r=0.530, p=0.016).CONCLUSION: T2D patients had a higher percentage of CD14+CD16+ monocytes and IL-1b levels than healthy donors. An increase in CD14+CD16+ monocytes above 6.8% associated with CVD risk markers in T2D patients.KEYWORDS: type 2 diabetes, monocytes, CD14, CD16, cardiovaskular disease risk marker</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2024-02-23</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>http://dx.doi.org/10.18585/inabj.v16i1.2798</dc:identifier><dc:identifier>10.18585/inabj.v16i1.2798</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 16 No 1 (2024); 79-87</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/2798/694</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>